Respiratory Failure: Clinical Trials

21 trials for Respiratory Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed. 21 Phase 2, 4 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 221Completed 21
Phase 14Completed 4
Phase 34Completed 4

Follow Respiratory Failure: new trials by email Literature Review of Respiratory Failure trials Research Report on Respiratory Failure

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sedation vs No Sedation in Mechanically Ventilated COPD Patients
Midalozam - Chronic Obstructive Pulmonary Disease, Respiratory Failure
Phase 2CompletedAl-Azhar University1002025-04-142026-06-02
CONFOCAL-2 Interventional Pilot Study
Autoregulation-based precision blood pressure management - Critical Illness, Respiratory Failure
Phase 1 / Phase 2CompletedQueen's University162022-07-292025-12-22
Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery
Intravenous Acetaminophen (room temperature), Intravenous Vitamin C (refrigerated), 5% Dextrose (room temperature) - Acute Respiratory Distress Syndrome, Critical Illness
Phase 2CompletedMassachusetts General Hospital4882021-10-132024-09-27
Nebulised Heparin in Patients With Severe COVID-19
Nebulised unfractionated heparin (UFH) - Covid19, Respiratory Failure
Phase 2 / Phase 3CompletedAustralian National University572020-11-012025-11-05
Tenecteplase in Patients With COVID-19
Tenecteplase, Placebo - COVID-19, Respiratory Failure
Phase 2CompletedHooman Poor132020-09-252023-04-06
Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation
Convalescent Plasma, Standard of Care - Covid19, Mechanical Ventilation Complication
Phase 2CompletedUniversity of Liege4752020-09-112024-10-29
Use of Angiotensin-(1-7) in COVID-19
Angiotensin-(1-7), Placebo - Infection, Coronavirus, Respiratory Failure
Phase 1 / Phase 2CompletedErasme University Hospital1122020-08-052021-11-09
Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure
Iloprost, Isotonic saline - COVID-19, Respiratory Failure
Phase 2CompletedPär Johansson802020-06-152024-05-07
Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection
Alteplase 50 MG [Activase] - Severe Acute Respiratory Syndrome, Respiratory Failure
Phase 2CompletedDenver Health and Hospital Authority502020-05-142022-01-20
A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19
Mefloquine, Hydroxychloroquine, Mefloquine + azithromycin + / - tocilizumab - Pneumonia, Viral, Respiratory Failure
Phase 2 / Phase 3CompletedBurnasyan Federal Medical Biophysical Center3202020-04-082021-01-27
Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19
Tirofiban Injection, Clopidogrel, Acetylsalicylic acid - Pneumonia, Viral, Corona Virus Infection
Phase 2CompletedUniversity of Milan52020-04-062020-04-29
Self-management of Sedative Therapy by Ventilated Patients
Dexmedetomidine - Critical Illness, Anxiety
Phase 2 / Phase 3CompletedMayo Clinic1612016-11-012025-10-02
CYCLE Pilot Randomized Trial
In-bed cycle ergometer (Restorative Therapies RT300 Supine), Routine physiotherapy - Intensive Care Unit Acquired Weakness, Critical Care
Phase 2CompletedMcMaster University1132015-03-012022-12-05
The Effect of Thiamine vs. Placebo on VO2 in Critical Illness
Thiamine - Critically Ill, Respiratory Failure
Phase 2CompletedBeth Israel Deaconess Medical Center662013-10-012017-10-02
Nebulized Hypertonic Saline for Mechanically Ventilated Children
Hypertonic saline (3%), Placebo (0.9% saline) - Respiratory Failure
Phase 1 / Phase 2CompletedUniversity Hospitals Cleveland Medical Center182013-10-012016-06-28
Vitamin D in Ventilated ICU Patients
Enteral Vitamin D3 50,000 IU, Enteral Vitamin D3 100,000IU, Inactive substance - Respiratory Failure
Phase 2CompletedEmory University312011-07-012017-01-09
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
IV Ganciclovir, Placebo - Acute Lung Injury, Acute Respiratory Distress Syndrome
Phase 2CompletedFred Hutchinson Cancer Center1602011-03-102018-08-21
Donor Simvastatin Treatment in Organ Transplantation
Simvastatin 80mg, Control Rx - Heart Failure, Respiratory Failure
Phase 2 / Phase 3CompletedHelsinki University Central Hospital842010-06-012017-09-19
Effect of Inspiratory Muscle Training on Duration of Mechanical Ventilation Support
IMST, Sham IMST - Respiratory Failure
Phase 1 / Phase 2CompletedUniversity of Florida762010-05-012013-12-11
Sedation Management in Pediatric Patients Supported on Mechanical Ventilation
Nurse Implemented Goal-Directed Comfort Algorithm - Respiratory Failure
Phase 2CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2452004-02-012015-10-07

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Respiratory Insufficiency (21)  ·  COVID-19 (6)  ·  Critical Illness (5)  ·  Coronavirus Infections (3)  ·  Respiratory Distress Syndrome (3)  ·  Pneumonia, Viral (2)  ·  Severe Acute Respiratory Syndrome (2)  ·  Acute Lung Injury (1)  ·  Anxiety Disorders (1)  ·  Cross Infection (1)  ·  Delirium (1)  ·  Embolism and Thrombosis (1)  ·  Heart Failure (1)  ·  Infections (1)  ·  Liver Failure (1)

Broader conditions

Respiration Disorders (21)  ·  Respiratory Tract Diseases (21)  ·  Lung Diseases (11)  ·  Infections (10)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Virus Diseases (8)  ·  Coronaviridae Infections (7)  ·  Disease Attributes (7)  ·  Nidovirales Infections (7)  ·  RNA Virus Infections (7)  ·  Respiratory Tract Infections (7)  ·  Pneumonia (6)  ·  Pneumonia, Viral (5)  ·  Coronavirus Infections (4)

Interventions

Sodium Chloride (2)  ·  Aspirin (1)  ·  Azithromycin (1)  ·  Clopidogrel (1)  ·  Dexmedetomidine (1)  ·  Etomidate (1)  ·  Fondaparinux (1)  ·  Ganciclovir (1)  ·  Glucose (1)  ·  Hydroxychloroquine (1)  ·  Iloprost (1)  ·  Mefloquine (1)  ·  Midazolam (1)  ·  Saline Solution (1)  ·  Saline Solution, Hypertonic (1)

Sponsors

Al-Azhar University (1)  ·  Australian National University (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Burnasyan Federal Medical Biophysical Center (1)  ·  Denver Health and Hospital Authority (1)  ·  Emory University (1)  ·  Erasme University Hospital (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Helsinki University Central Hospital (1)  ·  Hooman Poor (1)  ·  Massachusetts General Hospital (1)  ·  Mayo Clinic (1)  ·  McMaster University (1)  ·  Pär Johansson (1)

Countries

United States (13)  ·  Canada (2)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Finland (1)  ·  Italy (1)  ·  Russia (1)

Top investigators

Ajit Limaye, MD (1)  ·  Ana Martins Valle (1)  ·  Anders Perner, MD, PhD (1)  ·  Boyd Taylor Thompson, MD (1)  ·  Ernest E Moore, MD (1)  ·  Filippo Annoni (1)  ·  Frank MP van Haren, MD, PhD (1)  ·  Greg Martin, MD, MSc (1)  ·  Hooman Poor, MD (1)  ·  J Mocco, MD (1)  ·  Jeanne L Jacoby, MD (1)  ·  Karl B Lemstrom, MD, PhD (1)  ·  Katherine Berg, MD (1)  ·  Linda L Chlan, RN, PhD (1)  ·  Louise Kimball, PhD, RN (1)

Results publications

PMID 27059469, PMID 27419080, PMID 28829877, PMID 30558653, PMID 30956804, PMID 31352795, PMID 31455384, PMID 31741746, PMID 32838109, PMID 32847626, PMID 33287790, PMID 33331622, PMID 33502773, PMID 34592318, PMID 35244208, PMID 37355270, PMID 37889107, PMID 38762798, PMID 38865147, PMID 39231898, PMID 39317833, PMID 39432177, PMID 39467285, PMID 41788496

NIH funding

R01HL130881 (1), U01HL102547 (1)